Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Mandeep R Mehra, M.B.,B.S.

TitleProfessor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressBrigham and Womens Hospital
Executive Director,Ctr for Advanced Heart Disease
15 Francis St, -AB 326
Boston MA 02115
Phone6177328534
Fax6172645265

 Overview 
 overview
Dr. Mehra serves as Executive Director, Center for Advanced Heart Disease, Brigham and Women’s Hospital and is a Professor of Medicine at Harvard Medical School. Additionally, he is Editor-in-Chief, The Journal of Heart and Lung Transplantation.

Prior to joining the Brigham and Women’s Hospital, Dr. Mehra served as the Dr. Herbert Berger Endowed Professor of Medicine and Head of Cardiology as well as Assistant Dean for Clinical Services at the University of Maryland School of Medicine. Dr. Mehra has authored and published over 400 book chapters, manuscripts, editorials and abstracts focusing on all aspects of advanced heart failure and cardiac transplantation, treatment modalities, medical therapies and alternatives to transplantation. His specific research interests in cardiac transplantation focus on post-transplant coronary arterial disease (use of intravascular ultrasound and angioscopy), new immunosuppressive therapy to improve heart transplant outcomes (particularly in minority populations), and in bringing genomic and proteomic science to the bedside (to avoid the morbidity of endomyocardial biopsies). In the field of heart failure, his research has focused on the role of novel percutaneous cardiac support devices and serum markers to guide diagnosis and therapy. One important area of his focus is in developing international guidelines for care of the heart transplant candidate and process enhancement for improving performance measure adherence in heart failure. More recently, he has focused on bench research to understand the effects of cigarette smoke on the transplanted heart coronary vasculature and its interaction with the development of nephropathy in the presence of immunosuppression. Dr. Mehra is a Past-President of the International Society of Heart and Lung Transplantation (ISHLT) and served as the 2004 Program Chairman for the ISHLT Annual Scientific Meeting. He serves on the Executive Council of the Heart Failure Society of America (HFSA) as its treasurer, is a member of the HFSA Education Committee, Development Committee and co-chaired the 2007 and 2008 HFSA Annual Scientific Programs. He serves as a core member of the American Board of Internal Medicine’s testing committee on Advanced Heart Failure and Transplant Cardiology. Dr. Mehra is recognized as one of the country’s leading cardiologists in advanced heart failure and cardiac transplantation.

Currently, Dr. Mehra is enagaged in developing a platform for discovery in Cardiac Recovery of the Failing Heart, Fundamentals of Right Ventricular Dysfunction and in developing innovative care processes for Advanced Heart Failure with a focus on value as we transition into a new Healthcare Era.


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Gheorghiade M, Vaduganathan M, Ambrosy A, Böhm M, Campia U, Cleland JG, Fedele F, Fonarow GC, Maggioni AP, Mebazaa A, Mehra M, Metra M, Nodari S, Pang PS, Ponikowski P, Sabbah HN, Komajda M, Butler J. Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure. Heart Fail Rev. 2013 Mar; 18(2):107-22.
    View in: PubMed
  2. Esch JJ, Shah PB, Cockrill BA, Farber HW, Landzberg MJ, Mehra MR, Mullen MP, Opotowsky AR, Waxman AB, Lock JE, Marshall AC. Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: Initial clinical experience. J Heart Lung Transplant. 2013 Apr; 32(4):381-7.
    View in: PubMed
  3. Shukla A, Curtis AB, Mehra MR, Albert NM, Gheorghiade M, Heywood JT, Liu Y, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Fonarow GC. Factors Associated with Improvement in Utilization of Cardiac Resynchronization Therapy in Eligible Heart Failure Patients: Findings from IMPROVE HF. Pacing Clin Electrophysiol. 2013 Apr; 36(4):433-43.
    View in: PubMed
  4. Mehra MR, Domanski MJ. Should left ventricular assist device should be standard of care for patients with refractory heart failure who are not transplantation candidates?: left ventricular assist devices should be considered standard of care for patients with refractory heart failure who are not transplantation candidates. Circulation. 2012 Dec 18; 126(25):3081-7.
    View in: PubMed
  5. Shah P, Tang D, Shah K, Mehra MR. JHLT highlights 2011: Cardiothoracic transplantation, pulmonary hypertension, and mechanical circulatory support. J Heart Lung Transplant. 2012 Dec; 31(12):1257-61.
    View in: PubMed
  6. Mattu A, Mehra MR. Emergency Cardiovascular Care: From ED to CCU and Beyond. Cardiol Clin. 2012 Nov; 30(4):xiii-xiv.
    View in: PubMed
  7. Khanna A, Guo M, Mehra M, Royal W. Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains. J Neuroimmunol. 2013 Jan 15; 254(1-2):69-75.
    View in: PubMed
  8. Ambrosy AP, Fonarow GC, Albert NM, Curtis AB, Heywood JT, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Gheorghiade M. B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF. J Cardiovasc Med (Hagerstown). 2012 Jun; 13(6):360-7.
    View in: PubMed
  9. Mehra MR. Balancing the tightrope of cardiac allograft rejection: equations or experience? Circulation. 2012 Jun 19; 125(24):2971-4.
    View in: PubMed
  10. Reynolds D, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Mcbride ML, Inge PJ, Mehra MR, O'Connor CM, Walsh MN, Yancy CW, Fonarow GC. Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF. J Natl Med Assoc. 2012 May-Jun; 104(5-6):287-98.
    View in: PubMed
  11. Shah MR, Starling RC, Schwartz Longacre L, Mehra MR. Heart transplantation research in the next decade-a goal to achieving evidence-based outcomes: national heart, lung, and blood institute working group. J Am Coll Cardiol. 2012 Apr 3; 59(14):1263-9.
    View in: PubMed
  12. Fonarow GC, Albert NM, Curtis AB, Gheorghiade M, Liu Y, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW. Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF. J Am Heart Assoc. 2012 Feb; 1(1):16-26.
    View in: PubMed
  13. Walsh MN, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Liu Y, Mehra MR, O'Connor CM, Reynolds D, Yancy CW, Fonarow GC. Lack of association between electronic health record systems and improvement in use of evidence-based heart failure therapies in outpatient cardiology practices. Clin Cardiol. 2012 Mar; 35(3):187-96.
    View in: PubMed
  14. Greenberg BH, Anand IS, Burnett JC, Chin J, Dracup KA, Feldman AM, Force T, Francis GS, Houser SR, Hunt SA, Konstam MA, Lindenfeld J, Mann DL, Mehra MR, Paul SC, Piano MR, Ross HJ, Sabbah HN, Starling RC, Udelson JE, Yancy CW, Zile MR, Massie BM. The Heart Failure Society of America in 2020: a vision for the future. J Card Fail. 2012 Feb; 18(2):90-3.
    View in: PubMed
  15. Kirklin JK, Mehra MR. The dawn of the ISHLT Mechanical Assisted Circulatory Support (IMACS) Registry: fulfilling our mission. J Heart Lung Transplant. 2012 Feb; 31(2):115-6.
    View in: PubMed
  16. Park MH, Mehra MR. Pulmonary hypertension: the great leveler. J Am Coll Cardiol. 2012 Jan 17; 59(3):232-4.
    View in: PubMed
  17. Milani RV, Lavie CJ, Mehra MR, Ventura HO. Exercise training as treatment of depression in heart failure. J Am Coll Cardiol. 2012 Jan 17; 59(3):291.
    View in: PubMed
  18. Wilcox JE, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Heywood JT, Inge PJ, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Gheorghiade M. Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. Am Heart J. 2012 Jan; 163(1):49-56.e2.
    View in: PubMed
  19. Mehra MR, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Liu Y, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Fonarow GC. Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients. Pacing Clin Electrophysiol. 2012 Feb; 35(2):135-45.
    View in: PubMed
  20. Khanna AK, Xu J, Mehra MR. Antioxidant N-acetyl cysteine reverses cigarette smoke-induced myocardial infarction by inhibiting inflammation and oxidative stress in a rat model. Lab Invest. 2012 Feb; 92(2):224-35.
    View in: PubMed
  21. Harinstein ME, Flaherty JD, Fonarow GC, Mehra MR, Lang RM, Kim RJ, Cleland JG, Knight BP, Pang PS, Bonow RO, Gheorghiade M. Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge period. Heart. 2011 Oct; 97(19):1607-18.
    View in: PubMed
  22. Gheorghiade M, Albert NM, Curtis AB, Thomas Heywood J, McBride ML, Inge PJ, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Fonarow GC. Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF. Congest Heart Fail. 2012 Jan-Feb; 18(1):9-17.
    View in: PubMed
  23. Pang PS, Mehra M, Maggioni AP, Filippatos G, Middlebrooks J, Turlapaty P, Kazei D, Gheorghiade M. Rationale, design, and results from RENO-DEFEND 1: a randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure. Am Heart J. 2011 Jun; 161(6):1012-23.e3.
    View in: PubMed
  24. Berry GJ, Angelini A, Burke MM, Bruneval P, Fishbein MC, Hammond E, Miller D, Neil D, Revelo MP, Rodriguez ER, Stewart S, Tan CD, Winters GL, Kobashigawa J, Mehra MR. The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). J Heart Lung Transplant. 2011 Jun; 30(6):601-11.
    View in: PubMed
  25. Pandhi J, Gottdiener JS, Bartz TM, Kop WJ, Mehra MR. Comparison of characteristics and outcomes of asymptomatic versus symptomatic left ventricular dysfunction in subjects 65 years old or older (from the Cardiovascular Health Study). Am J Cardiol. 2011 Jun 1; 107(11):1667-74.
    View in: PubMed
  26. Nair N, Ball T, Uber PA, Mehra MR. Current and future challenges in therapy for antibody-mediated rejection. J Heart Lung Transplant. 2011 Jun; 30(6):612-7.
    View in: PubMed
  27. Fonarow GC, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Liu Y, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW. Associations between outpatient heart failure process-of-care measures and mortality. Circulation. 2011 Apr 19; 123(15):1601-10.
    View in: PubMed
  28. Ramani GV, Mehra MR. Risk assessment in critically ill patients awaiting transplantation: a step forward. Rev Esp Cardiol. 2011 Mar; 64(3):175-6.
    View in: PubMed
  29. Beitelshees AL, Horenstein RB, Vesely MR, Mehra MR, Shuldiner AR. Pharmacogenetics and clopidogrel response in patients undergoing percutaneous coronary interventions. Clin Pharmacol Ther. 2011 Mar; 89(3):455-9.
    View in: PubMed
  30. O'Connor CM, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, McBride ML, Inge PJ, Mehra MR, Reynolds D, Walsh MN, Yancy CW, Fonarow GC. patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial). Am J Cardiol. 2011 Jan 15; 107(2):250-8.
    View in: PubMed
  31. Milani RV, Lavie CJ, Mehra MR, Ventura HO. Impact of exercise training and depression on survival in heart failure due to coronary heart disease. Am J Cardiol. 2011 Jan; 107(1):64-8.
    View in: PubMed
  32. Tavora F, Munivenkatappa R, Papadimitriou J, Drachenberg C, Sailey C, Mehra M, Burke A. Endothelitis in cardiac allograft biopsy specimens: possible relationship to antibody-mediated rejection. J Heart Lung Transplant. 2011 Apr; 30(4):435-44.
    View in: PubMed
  33. Walsh MN, Yancy CW, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Inge PJ, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Fonarow GC. Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE HF. J Card Fail. 2010 Dec; 16(12):940-9.
    View in: PubMed
  34. Adams KF, Mehra MR, Oren RM, O'Connor CM, Chiong JR, Ghali JK, Lenihan DJ, Dunlap SH, Patterson JH, Schwartz TA, Felker GM. Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failure. Am Heart J. 2010 Dec; 160(6):1142-8.
    View in: PubMed
  35. Gheorghiade M, Thyssen A, Zolynas R, Nadar VK, Greenberg BH, Mehra M, Sun X, Tian H, Plotnikov AN, Burton P. Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure. J Heart Lung Transplant. 2011 Feb; 30(2):218-26.
    View in: PubMed
  36. Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Inge PJ, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010 Aug 10; 122(6):585-96.
    View in: PubMed
  37. Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Gheorghiade M, Inge PJ, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF. Circ Heart Fail. 2010 Sep; 3(5):596-605.
    View in: PubMed
  38. Uber P, Summers K, Mehra MR. Clinicians and nutraceutical use in cardiology patients: ignorance and neglect. Ann Intern Med. 2010 Jul 6; 153(1):65-6.
    View in: PubMed
  39. Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA, Madsen J, Parameshwar J, Starling RC, Uber PA. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant. 2010 Jul; 29(7):717-27.
    View in: PubMed
  40. Mehra MR, Parameshwar J. Gene expression profiling and cardiac allograft rejection monitoring: is IMAGE just a mirage? J Heart Lung Transplant. 2010 Jun; 29(6):599-602.
    View in: PubMed
  41. Albert NM, Fonarow GC, Yancy CW, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride M, Mehra MR, O'Connor CM, Reynolds D, Walsh MN. Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF). Am J Cardiol. 2010 Jun 15; 105(12):1773-9.
    View in: PubMed
  42. Walsh MN, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Fonarow GC. Electronic health records and quality of care for heart failure. Am Heart J. 2010 Apr; 159(4):635-642.e1.
    View in: PubMed
  43. Felker GM, Pang PS, Adams KF, Cleland JG, Cotter G, Dickstein K, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pina IL, Ponikowski P, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Gheorghiade M. Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward. Circ Heart Fail. 2010 Mar; 3(2):314-25.
    View in: PubMed
  44. Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. Am J Cardiol. 2010 Apr 15; 105(8):1140-6.
    View in: PubMed
  45. Park MH, Ramani GV, Kop WJ, Uber PA, Mehra MR. Exercise-uncovered pulmonary arterial hypertension and pharmacologic therapy: Clinical benefits. J Heart Lung Transplant. 2010 Feb; 29(2):228-9.
    View in: PubMed
  46. Albert NM, Fonarow GC, Yancy CW, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride M, Mehra MR, O'Connor CM, Reynolds D, Walsh MN. Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Am Heart J. 2010 Feb; 159(2):238-44.
    View in: PubMed
  47. Ramani GV, Uber PA, Mehra MR. Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc. 2010 Feb; 85(2):180-95.
    View in: PubMed
  48. Yancy CW, Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN. Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF). Am J Cardiol. 2010 Jan 15; 105(2):255-60.
    View in: PubMed
  49. Mehra MR, Uber PA, Benitez RM. Gene-based bio-signature patterns and cardiac allograft rejection. Heart Fail Clin. 2010 Jan; 6(1):87-92.
    View in: PubMed
  50. Zile MR, Colombo PC, Mehra M, Greenberg B, Brown S, Konstam MA. Progressive improvement in cardiac performance with continuous aortic flow augmentation (aortic flow therapy) in patients hospitalized with severe heart failure: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM). J Heart Lung Transplant. 2010 Jan; 29(1):86-92.
    View in: PubMed
  51. Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK, Lenihan DJ, Oren RM, Wagoner LE, Schwartz TA, Adams KF. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail. 2010 Mar; 16(3):230-8.
    View in: PubMed
  52. Curtis AB, Yancy CW, Albert NM, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, Oconnor CM, Reynolds D, Walsh MN, Fonarow GC. Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J. 2009 Dec; 158(6):956-64.
    View in: PubMed
  53. Adams KF, Piña IL, Ghali JK, Wagoner LE, Dunlap SH, Schwartz TA, Stough WG, Mehra MR, Felker GM, Chiong JR, Patterson JH, Kim J, Butler J, Oren RM. Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failure. Am Heart J. 2009 Dec; 158(6):965-71.
    View in: PubMed
  54. Khanna AK, Xu J, Uber PA, Burke AP, Baquet C, Mehra MR. Tobacco smoke exposure in either the donor or recipient before transplantation accelerates cardiac allograft rejection, vascular inflammation, and graft loss. Circulation. 2009 Nov 3; 120(18):1814-21.
    View in: PubMed
  55. Mehra MR, Uber PA, Lavie CJ, Milani RV, Park MH, Ventura HO. High-density lipoprotein cholesterol levels and prognosis in advanced heart failure. J Heart Lung Transplant. 2009 Sep; 28(9):876-80.
    View in: PubMed
  56. Mehra MR, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, O'Connor CM, Reynolds D, Walsh MN, Fonarow GC. Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. Heart Rhythm. 2009 Dec; 6(12):1727-34.
    View in: PubMed
  57. Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol. 2009 Aug 11; 54(7):585-94.
    View in: PubMed
  58. Lavie CJ, Mehra MR. Statins and advanced heart failure--alive but barely breathing after CORONA and GISSI-HF. Congest Heart Fail. 2009 Jul-Aug; 15(4):157-8.
    View in: PubMed
  59. Uber PA, Ross HJ, Zuckermann AO, Sweet SC, Corris PA, McNeil K, Mehra MR. Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory. J Heart Lung Transplant. 2009 Jul; 28(7):655-60.
    View in: PubMed
  60. Gheorghiade M, Adams KF, Cleland JG, Cotter G, Felker GM, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pang PS, Piña IL, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Stockbridge N. Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J. 2009 Jun; 157(6):957-70.
    View in: PubMed
  61. Lavie CJ, O'Keefe JH, Milani RV, Ventura HO, Mehra MR. New data on the clinical impact of exercise training, fish oils, and statins in heart failure. Phys Sportsmed. 2009 Jun; 37(2):22-8.
    View in: PubMed
  62. Khanna AK, Xu J, Baquet C, Mehra MR. Adverse effects of nicotine and immunosuppression on proximal tubular epithelial cell viability, tissue repair and oxidative stress gene expression. J Heart Lung Transplant. 2009 Jun; 28(6):612-20.
    View in: PubMed
  63. Adams KF, Patterson JH, Patterson JH, Oren RM, Mehra MR, O'Connor CM, Piña IL, Miller AB, Chiong JR, Dunlap SH, Cotts WG, Felker GM, Schocken DD, Schwartz TA, Ghali JK. Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry. Am Heart J. 2009 May; 157(5):926-32.
    View in: PubMed
  64. Yancy CW, Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN. Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J. 2009 Apr; 157(4):754-62.e2.
    View in: PubMed
  65. Kobashigawa J, Mehra M, West L, Kerman R, George J, Rose M, Zeevi A, Reinsmoen N, Patel J, Reed EF. Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant. 2009 Mar; 28(3):213-25.
    View in: PubMed
  66. Mehra MR, Uber PA, Benitez RM. Cardiomyopathy and the dilemma of geometric mitral regurgitation. Curr Opin Cardiol. 2009 Mar; 24(2):179-83.
    View in: PubMed
  67. Mehra MR, Rockman HA, Greenberg BH. Highlights of the 2008 Scientific Sessions of the Heart Failure Society of America. Toronto, Ontario, Canada, September 20-23, 2008. J Am Coll Cardiol. 2009 Feb 10; 53(6):514-22.
    View in: PubMed
  68. Majeed F, Kop WJ, Poston RS, Kallam S, Mehra MR. Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices. Nat Clin Pract Cardiovasc Med. 2009 Feb; 6(2):147-57.
    View in: PubMed
  69. Flaherty JD, Bax JJ, De Luca L, Rossi JS, Davidson CJ, Filippatos G, Liu PP, Konstam MA, Greenberg B, Mehra MR, Breithardt G, Pang PS, Young JB, Fonarow GC, Bonow RO, Gheorghiade M. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J Am Coll Cardiol. 2009 Jan 20; 53(3):254-63.
    View in: PubMed
  70. Shah KB, Kop WJ, Christenson RH, Diercks DB, Kuo D, Henderson S, Hanson K, Mehra MR, deFilippi CR. Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea. Clin Chem. 2009 Jan; 55(1):59-67.
    View in: PubMed
  71. Rogers JS, Zakaria S, Thom KA, Flammer KM, Kanno M, Mehra MR. Immune reconstitution inflammatory syndrome and human immunodeficiency virus-associated myocarditis. Mayo Clin Proc. 2008 Nov; 83(11):1275-9.
    View in: PubMed
  72. Greenberg B, Czerska B, Delgado RM, Bourge R, Zile MR, Silver M, Klapholz M, Haeusslein E, Mehra MR, Mather P, Abraham WT, Neaton JD, Brown BS, Parker IC, Konstam MA. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM). Circulation. 2008 Sep 16; 118(12):1241-9.
    View in: PubMed
  73. Schwartz DJ, Kop WJ, Park MH, Vesely MR, Li S, Mehra MR, Gottdiener JS. Evidence for early right ventricular and septal mechanical activation (interventricular dyssynchrony) in pulmonary hypertension. Am J Cardiol. 2008 Nov 1; 102(9):1273-7.
    View in: PubMed
  74. Brown JR, Uber PA, Mehra MR. The progressive cardiorenal syndrome in heart failure: mechanisms and therapeutic insights. Curr Treat Options Cardiovasc Med. 2008 Aug; 10(4):342-8.
    View in: PubMed
  75. O'Connell JB, McCarthy PM, Sopko G, Filippatos GS, Piña IL, Konstam MA, Young JB, Miller LW, Mehra MR, Roland E, Blair JE, Farrar DJ, Gheorghiade M. Mechanical circulatory support devices for acute heart failure syndromes: considerations for clinical trial design. Heart Fail Rev. 2009 Jun; 14(2):101-12.
    View in: PubMed
  76. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail. 2008 Jul; 1(2):98-106.
    View in: PubMed
  77. Reicher B, Poston RS, Mehra MR, Joshi A, Odonkor P, Kon Z, Reyes PA, Zimrin DA. Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. Am Heart J. 2008 Apr; 155(4):661-7.
    View in: PubMed
  78. Mehra MR. The cardiac allograft is going up in smoke: a call to action. Am J Transplant. 2008 Apr; 8(4):737-8.
    View in: PubMed
  79. Mehra MR, Reyes P, Benitez RM, Zimrin D, Gammie JS. Surgery for severe mitral regurgitation and left ventricular failure: what do we really know? J Card Fail. 2008 Mar; 14(2):145-50.
    View in: PubMed
  80. Mehra MR, Kobashigawa JA, Deng MC, Fang KC, Klingler TM, Lal PG, Rosenberg S, Uber PA, Starling RC, Murali S, Pauly DF, Dedrick R, Walker MG, Zeevi A, Eisen HJ. Clinical implications and longitudinal alteration of peripheral blood transcriptional signals indicative of future cardiac allograft rejection. J Heart Lung Transplant. 2008 Mar; 27(3):297-301.
    View in: PubMed
  81. Mehra MR, Rockman HA, Greenberg BH. Highlights of the 2007 Scientific Meeting of the Heart Failure Society of America: Washington, DC, September 16-19, 2007. J Am Coll Cardiol. 2008 Jan 22; 51(3):320-7.
    View in: PubMed
  82. Mehra MR, Uber PA, Ventura HO. Death messengers. BMJ. 2007 Dec 22; 335(7633):1296-7.
    View in: PubMed
  83. Vesely MR, Li S, Kop WJ, Reese A, Marshall J, Shorofsky SR, Gottlieb SS, Mehra MR, Gottdiener JS. Test-retest reliability of assessment for intraventricular dyssynchrony by tissue Doppler imaging echocardiography. Am J Cardiol. 2008 Mar 1; 101(5):645-50.
    View in: PubMed
  84. Shah KB, Nolan MM, Rao K, Wang DJ, Christenson RH, Shanholtz CB, Mehra MR, Gottlieb SS. The characteristics and prognostic importance of NT-ProBNP concentrations in critically ill patients. Am J Med. 2007 Dec; 120(12):1071-7.
    View in: PubMed
  85. Mehra MR, Kobashigawa JA, Deng MC, Fang KC, Klingler TM, Lal PG, Rosenberg S, Uber PA, Starling RC, Murali S, Pauly DF, Dedrick R, Walker MG, Zeevi A, Eisen HJ. Transcriptional signals of T-cell and corticosteroid-sensitive genes are associated with future acute cellular rejection in cardiac allografts. J Heart Lung Transplant. 2007 Dec; 26(12):1255-63.
    View in: PubMed
  86. Anand RG, Ventura HO, Mehra MR. Is heart failure more prevalent in patients with peripheral arterial disease? A meta-analysis. Congest Heart Fail. 2007 Nov-Dec; 13(6):319-22.
    View in: PubMed
  87. Mandras SA, Uber PA, Mehra MR. Sexual activity and chronic heart failure. Mayo Clin Proc. 2007 Oct; 82(10):1203-10.
    View in: PubMed
  88. Lavie CJ, Milani RV, Ventura HO, Cardenas GA, Mehra MR, Messerli FH. Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol. 2007 Nov 1; 100(9):1460-4.
    View in: PubMed
  89. Johnson MR, Aaronson KD, Canter CE, Kirklin JK, Mancini DM, Mehra MR, Radovancevic B, Taylor DO, Webber SA. Heart retransplantation. Am J Transplant. 2007 Sep; 7(9):2075-81.
    View in: PubMed
  90. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, Mehra M, O'Connor CM, Reynolds D, Walsh MN. Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J. 2007 Jul; 154(1):12-38.
    View in: PubMed
  91. Mehra MR, McCluskey T, Barr M, Bourge RC, Jessup ML, Mancini D, Radovancevic B, Rayburn B, Taylor DO, Lilly-Hersley J, Linde P. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC. Am Heart J. 2007 Jun; 153(6):932-40.
    View in: PubMed
  92. Uber PA, Mehra MR. Induction therapy in heart transplantation: is there a role? J Heart Lung Transplant. 2007 Mar; 26(3):205-9.
    View in: PubMed
  93. Lavie CJ, Milani RV, Ventura HO, Mehra MR. Peak oxygen consumption and heart failure prognosis in women. J Am Coll Cardiol. 2007 Jan 23; 49(3):375; author reply 375-6.
    View in: PubMed
  94. Mehra MR, Uber PA. Genomic biomarkers and heart transplantation. Heart Fail Clin. 2007 Jan; 3(1):83-6.
    View in: PubMed
  95. Greenberg B, Mehra MR. All patients with heart failure and intraventricular conduction defect or dyssynchrony should not receive cardiac resynchronization therapy. Circulation. 2006 Dec 12; 114(24):2685-90; discussion 2691.
    View in: PubMed
  96. Starling RC, Pham M, Valantine H, Miller L, Eisen H, Rodriguez ER, Taylor DO, Yamani MH, Kobashigawa J, McCurry K, Marboe C, Mehra MR, Zuckerman A, Deng MC. Molecular testing in the management of cardiac transplant recipients: initial clinical experience. J Heart Lung Transplant. 2006 Dec; 25(12):1389-95.
    View in: PubMed
  97. Milani RV, Lavie CJ, Mehra MR, Ventura HO. Understanding the basics of cardiopulmonary exercise testing. Mayo Clin Proc. 2006 Dec; 81(12):1603-11.
    View in: PubMed
  98. Khanna AK, Mehra MR. Targeted in vitro and in vivo gene transfer into T lymphocytes: potential of direct inhibition of allo-immune activation. BMC Immunol. 2006; 7:26.
    View in: PubMed
  99. Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med. 2006 Sep 25; 166(17):1805-13.
    View in: PubMed
  100. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. J Heart Lung Transplant. 2006 Sep; 25(9):1024-42.
    View in: PubMed
  101. Mehra MR, Jessup M, Gronda E, Costanzo MR. Rationale and process: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. J Heart Lung Transplant. 2006 Sep; 25(9):1001-2.
    View in: PubMed
  102. Greenberg BH, Mehra M, Teerlink JR, Ordronneau P, McCollum D, Gilbert EM. COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure. Am J Cardiol. 2006 Oct 2; 98(7A):53L-59L.
    View in: PubMed
  103. Saba MM, Ventura HO, Saleh M, Mehra MR. Ancient Egyptian medicine and the concept of heart failure. J Card Fail. 2006 Aug; 12(6):416-21.
    View in: PubMed
  104. Milani RV, Mehra MR, Lavie CJ, Ventura HO. Comparison of cardiac and peripheral arterial stiffening and ventriculovascular uncoupling in patients with uncomplicated hypertension versus patients with hypertension after heart transplantation. Am J Cardiol. 2006 Sep 15; 98(6):789-92.
    View in: PubMed
  105. Kobashigawa JA, Starling RC, Mehra MR, Kormos RL, Bhat G, Barr ML, Sigouin CS, Kolesar J, Fitzsimmons W. Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients. J Heart Lung Transplant. 2006 Sep; 25(9):1063-9.
    View in: PubMed
  106. Mehra MR, Uber PA, Walther D, Vesely M, Wohlgemuth JG, Prentice J, Tayama D, Billingham M. Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation: more than a hemodynamic marker. Circulation. 2006 Jul 4; 114(1 Suppl):I21-6.
    View in: PubMed
  107. Mehra MR, Uber PA, Kaplan B. Immunosuppression in cardiac transplantation: science, common sense and the heart of the matter. Am J Transplant. 2006 Jun; 6(6):1243-5.
    View in: PubMed
  108. Mehra MR. Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am J Transplant. 2006 Jun; 6(6):1248-56.
    View in: PubMed
  109. Mehra MR, Lavie CJ, Ventura HO, Milani RV. Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J Heart Lung Transplant. 2006 Jul; 25(7):834-8.
    View in: PubMed
  110. Packer M, Abraham WT, Mehra MR, Yancy CW, Lawless CE, Mitchell JE, Smart FW, Bijou R, O'Connor CM, Massie BM, Pina IL, Greenberg BH, Young JB, Fishbein DP, Hauptman PJ, Bourge RC, Strobeck JE, Murali S, Schocken D, Teerlink JR, Levy WC, Trupp RJ, Silver MA. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol. 2006 Jun 6; 47(11):2245-52.
    View in: PubMed
  111. Deng MC, Eisen HJ, Mehra MR. Methodological challenges of genomic research--the CARGO study. Am J Transplant. 2006 May; 6(5 Pt 1):1086-7.
    View in: PubMed
  112. Kobashigawa JA, Tobis JM, Mentzer RM, Valantine HA, Bourge RC, Mehra MR, Smart FW, Miller LW, Tanaka K, Li H, Gjertson DW, Gordon RD. Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial. Am J Transplant. 2006 May; 6(5 Pt 1):993-7.
    View in: PubMed
  113. Thorn EM, Mehra MR. Imaging markers of adverse remodeling: from organ to organelle. Heart Fail Clin. 2006 Apr; 2(2):117-27.
    View in: PubMed
  114. Mehra MR. Optimizing outcomes in the patient with acute decompensated heart failure. Am Heart J. 2006 Mar; 151(3):571-9.
    View in: PubMed
  115. Mehra MR, Feller E, Rosenberg S. The promise of protein-based and gene-based clinical markers in heart transplantation: from bench to bedside. Nat Clin Pract Cardiovasc Med. 2006 Mar; 3(3):136-43.
    View in: PubMed
  116. Milani RV, Lavie CJ, Mehra MR, Ventura HO, Kurtz JD, Messerli FH. Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol. 2006 Apr 1; 97(7):959-63.
    View in: PubMed
  117. Deng MC, Eisen HJ, Mehra MR, Billingham M, Marboe CC, Berry G, Kobashigawa J, Johnson FL, Starling RC, Murali S, Pauly DF, Baron H, Wohlgemuth JG, Woodward RN, Klingler TM, Walther D, Lal PG, Rosenberg S, Hunt S. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant. 2006 Jan; 6(1):150-60.
    View in: PubMed
  118. Woods DM, Johnson J, Holl JL, Mehra M, Thomas EJ, Ogata ES, Lannon C. Anatomy of a patient safety event: a pediatric patient safety taxonomy. Qual Saf Health Care. 2005 Dec; 14(6):422-7.
    View in: PubMed
  119. Mehra MR, Zucker MJ, Wagoner L, Michler R, Boehmer J, Kovarik J, Vasquez A. A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation. J Heart Lung Transplant. 2005 Sep; 24(9):1297-304.
    View in: PubMed
  120. Hauptman PJ, Mehra MR. It is time to stop ignoring malignancy in heart transplantation: a call to arms. J Heart Lung Transplant. 2005 Aug; 24(8):1111-3.
    View in: PubMed
  121. Potluri SP, Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO. Relationship among epicardial coronary disease, tissue myocardial perfusion, and survival in heart transplantation. J Heart Lung Transplant. 2005 Aug; 24(8):1019-25.
    View in: PubMed
  122. Mehra MR. The emergence of genomic and proteomic biomarkers in heart transplantation. J Heart Lung Transplant. 2005 Jul; 24(7 Suppl):S213-8.
    View in: PubMed
  123. Mitchell JA, Ventura HO, Mehra MR. Early recognition and treatment of hypertensive heart disease. Curr Opin Cardiol. 2005 Jul; 20(4):282-9.
    View in: PubMed
  124. Marboe CC, Billingham M, Eisen H, Deng MC, Baron H, Mehra M, Hunt S, Wohlgemuth J, Mahmood I, Prentice J, Berry G. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. J Heart Lung Transplant. 2005 Jul; 24(7 Suppl):S219-26.
    View in: PubMed
  125. Kadish A, Mehra M. Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy. Circulation. 2005 Jun 21; 111(24):3327-35.
    View in: PubMed
  126. Evans RW, Williams GE, Baron HM, Deng MC, Eisen HJ, Hunt SA, Khan MM, Kobashigawa JA, Marton EN, Mehra MR, Mital SR. The economic implications of noninvasive molecular testing for cardiac allograft rejection. Am J Transplant. 2005 Jun; 5(6):1553-8.
    View in: PubMed
  127. Kobashigawa JA, Tobis JM, Starling RC, Tuzcu EM, Smith AL, Valantine HA, Yeung AC, Mehra MR, Anzai H, Oeser BT, Abeywickrama KH, Murphy J, Cretin N. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol. 2005 May 3; 45(9):1532-7.
    View in: PubMed
  128. Ventura HO, Mehra MR. Bloodletting as a cure for dropsy: heart failure down the ages. J Card Fail. 2005 May; 11(4):247-52.
    View in: PubMed
  129. Ventura HO, Mehra MR. The interaction of vascular stiffness and cardiovascular events in women: insights from The Heart and Estrogen/Progestin Replacement Study. Chest. 2005 May; 127(5):1477-80.
    View in: PubMed
  130. Eisen HJ, Kobashigawa J, Keogh A, Bourge R, Renlund D, Mentzer R, Alderman E, Valantine H, Dureau G, Mancini D, Mamelok R, Gordon R, Wang W, Mehra M, Constanzo MR, Hummel M, Johnson J. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant. 2005 May; 24(5):517-25.
    View in: PubMed
  131. Mehra MR, Uber PA, Prasad A, Scott RL, Park MH. Recrudescent tobacco exposure following heart transplantation: clinical profiles and relationship with athero-thrombosis risk markers. Am J Transplant. 2005 May; 5(5):1137-40.
    View in: PubMed
  132. Strickberger SA, Conti J, Daoud EG, Havranek E, Mehra MR, Piña IL, Young J. Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation. 2005 Apr 26; 111(16):2146-50.
    View in: PubMed
  133. Ventura HO, Mehra MR. Improvement of heart failure after renal transplantation: the complex maze of cardio-renal interaction. J Am Coll Cardiol. 2005 Apr 5; 45(7):1061-3.
    View in: PubMed
  134. Mehra MR, Maisel A. B-type natriuretic peptide in heart failure: diagnostic, prognostic, and therapeutic use. Crit Pathw Cardiol. 2005 Mar; 4(1):10-20.
    View in: PubMed
  135. Goel R, Johnson F, Mehra MR. Brain injury and ventricular dysfunction: insights into reversible heart failure. Congest Heart Fail. 2005 Mar-Apr; 11(2):99-101.
    View in: PubMed
  136. Wu AH, Ballantyne CM, Short BC, Torre-Amione G, Young JB, Ventura HO, Eisen HJ, Radovancevic B, Rayburn BK, Lake KD, Yancy CW, Taylor DO, Mehra MR, Kubo SH, Fishbein DP, Zhao XQ, O'Brien KD. Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry. Am J Cardiol. 2005 Feb 1; 95(3):367-72.
    View in: PubMed
  137. Mehra MR, Griffith BP. Is mitral regurgitation a viable treatment target in heart failure? The plot just thickened. J Am Coll Cardiol. 2005 Feb 1; 45(3):388-90.
    View in: PubMed
  138. Maisel A, Mehra MR. Understanding B-type natriuretic peptide and its role in diagnosing and monitoring congestive heart failure. Clin Cornerstone. 2005; 7 Suppl 1:S7-17.
    View in: PubMed
  139. Alaeddini J, Uber PA, Park MH, Scott RL, Ventura HO, Mehra MR. Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure. Am J Cardiol. 2004 Dec 1; 94(11):1475-7.
    View in: PubMed
  140. Mehra MR, Uber PA, Park MH, Ventura HO, Scott RL. Corticosteroid weaning in the tacrolimus and mycophenolate era in heart transplantation: clinical and neurohormonal benefits. Transplant Proc. 2004 Dec; 36(10):3152-5.
    View in: PubMed
  141. Mehra MR, Milani RV, Richie MB, Uber PA, Park MH, Ventura HO, Scott RL, Lavie CJ. Ventricular-vascular uncoupling increases expression of B-type natriuretic peptide in heart transplantation. Transplant Proc. 2004 Dec; 36(10):3149-51.
    View in: PubMed
  142. Lavie CJ, Mehra MR, Milani RV. Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J. 2005 Jan; 26(1):5-7.
    View in: PubMed
  143. Morshedi-Meibodi A, Menuet R, McFadden M, Ventura HO, Mehra MR. Is it constrictive pericarditis or restrictive cardiomyopathy? A systematic approach. Congest Heart Fail. 2004 Nov-Dec; 10(6):309-12.
    View in: PubMed
  144. Park MH, Scott RL, Uber PA, Ventura HO, Mehra MR. Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension. Congest Heart Fail. 2004 Sep-Oct; 10(5):221-5.
    View in: PubMed
  145. Nachimuthu S, Uber PA, Balasundaram P, Mehra MR. CHF: "compressive" heart failure? A clinical review of metastatic cardiac tumors. Congest Heart Fail. 2004 Sep-Oct; 10(5):254-6.
    View in: PubMed
  146. Silver MA, Maisel A, Yancy CW, McCullough PA, Burnett JC, Francis GS, Mehra MR, Peacock WF, Fonarow G, Gibler WB, Morrow DA, Hollander J. BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail. 2004 Sep-Oct; 10(5 Suppl 3):1-30.
    View in: PubMed
  147. Mehra MR, Uber PA, Potluri S, Ventura HO, Scott RL, Park MH. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. Am J Cardiol. 2004 Aug 15; 94(4):454-8.
    View in: PubMed
  148. Mehra MR, Kobashigawa JA. Advances in heart and lung transplantation 2004: Report from the 24th International Society for Heart and Lung Transplantation Annual Meeting, San Francisco, April 21-24, 2004. J Heart Lung Transplant. 2004 Aug; 23(8):925-30.
    View in: PubMed
  149. Milani RV, Lavie CJ, Mehra MR. Cardiopulmonary exercise testing: how do we differentiate the cause of dyspnea? Circulation. 2004 Jul 27; 110(4):e27-31.
    View in: PubMed
  150. Mehra MR, Benza R, Deng MC, Russell S, Webber S. Surrogate markers for late cardiac allograft survival. Am J Transplant. 2004 Jul; 4(7):1184-91.
    View in: PubMed
  151. Mehra MR, Raval NY. Metaanalysis of statins and survival in de novo cardiac transplantation. Transplant Proc. 2004 Jun; 36(5):1539-41.
    View in: PubMed
  152. Garrity ER, Mehra MR. An update on clinical outcomes in heart and lung transplantation. Transplantation. 2004 May 15; 77(9 Suppl):S68-74.
    View in: PubMed
  153. Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO, Harris BC, Frohlich ED. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol. 2004 May 5; 43(9):1590-5.
    View in: PubMed
  154. Mehra MR, Greenberg BH. Cardiac resynchronization therapy: caveat medicus! J Am Coll Cardiol. 2004 Apr 7; 43(7):1145-8.
    View in: PubMed
  155. Mehra MR. Ventricular assist devices: destination therapy or just another stop on the road? Curr Heart Fail Rep. 2004 Apr-May; 1(1):36-40.
    View in: PubMed
  156. Milani RV, Lavie CJ, Mehra MR. Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol. 2004 Mar 17; 43(6):1056-61.
    View in: PubMed
  157. Mehra MR, Uber PA, Ventura HO, Scott RL, Park MH. The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol. 2004 Mar 3; 43(5):806-10.
    View in: PubMed
  158. Lavie CJ, Milani RV, Mehra MR. Peak exercise oxygen pulse and prognosis in chronic heart failure. Am J Cardiol. 2004 Mar 1; 93(5):588-93.
    View in: PubMed
  159. Ventura HO, Mehra MR. The growing burden of heart failure: the "syndemic" is reaching Latin America. Am Heart J. 2004 Mar; 147(3):386-9.
    View in: PubMed
  160. Mehra MR, Uber PA, Uber WE, Ventura HO. Destination therapy in late-stage heart failure. Coron Artery Dis. 2004 Mar; 15(2):87-90.
    View in: PubMed
  161. Mehra MR, Gheorghiade M, Bonow RO. Mitral regurgitation in chronic heart failure: more questions than answers? Curr Cardiol Rep. 2004 Mar; 6(2):96-9.
    View in: PubMed
  162. Ventura HO, Mehra MR. White coat hypertension and sleep apnea: is there a link? Chest. 2004 Mar; 125(3):805-7.
    View in: PubMed
  163. Potluri S, Ventura HO, Mulumudi M, Mehra MR. Cardiac troponin levels in heart failure. Cardiol Rev. 2004 Jan-Feb; 12(1):21-5.
    View in: PubMed
  164. Ventura HO, Mehra MR. The historical odyssey of cardiac transplantation. J La State Med Soc. 2003 Nov-Dec; 155(6):344-7.
    View in: PubMed
  165. File E, Mehra M, Nair S, Dumas-Hicks D, Perrillo R. Allograft transmission of hepatitis C virus infection from infected donors in cardiac transplantation. Transplantation. 2003 Oct 15; 76(7):1096-100.
    View in: PubMed
  166. Park MH, Uber PA, Scott RL, Mehra MR. B-type natriuretic peptide in heart transplantation: an important marker of allograft performance. Heart Fail Rev. 2003 Oct; 8(4):359-63.
    View in: PubMed
  167. Thatipelli MR, Uber PA, Mehra MR. Isolated tricuspid stenosis and heart failure: a focus on carcinoid heart disease. Congest Heart Fail. 2003 Sep-Oct; 9(5):294-6.
    View in: PubMed
  168. Ventura HO, Mehra MR. C-Reactive protein and cardiac allograft vasculopathy. is inflammation the critical link? J Am Coll Cardiol. 2003 Aug 6; 42(3):483-5.
    View in: PubMed
  169. Ventura HO, Mehra MR. Hippocrates and prognosis in heart failure: the challenge of static and dynamic measurements. Am Heart J. 2003 Aug; 146(2):215-7.
    View in: PubMed
  170. Krishnan P, Ventura HO, Uber PA, Arcement LM, Mehra MR. Treatment of hypertension for patients with diastolic dysfunction. Curr Opin Cardiol. 2003 Jul; 18(4):272-7.
    View in: PubMed
  171. Mehra MR, Uber PA. Diverse populations, new techniques: non-surgical advances in heart failure 2003. Congest Heart Fail. 2003 Jul-Aug; 9(4):189-90.
    View in: PubMed
  172. Mehra MR, Uber PA, Francis GS. Heart failure therapy at a crossroad: are there limits to the neurohormonal model? J Am Coll Cardiol. 2003 May 7; 41(9):1606-10.
    View in: PubMed
  173. Ventura HO, Potluri S, Mehra MR. The conundrum of sleep breathing disorders in heart failure. Chest. 2003 May; 123(5):1332-4.
    View in: PubMed
  174. Alaeddini J, Uber P, Park MH, Scott RL, Mehra MR. Sildenafil and assessment of pulmonary arterial reactivity in heart failure. Congest Heart Fail. 2003 May-Jun; 9(3):176-8.
    View in: PubMed
  175. Mehra MR, Uber PA. TOR inhibitors and cardiac allograft vasculopathy: is inhibition of intimal thickening an adequate surrogate of benefit? J Heart Lung Transplant. 2003 May; 22(5):501-4.
    View in: PubMed
  176. Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol. 2003 Apr 1; 91(7):891-4.
    View in: PubMed
  177. Mehra MR, Uber PA, Uber WE, Scott RL, Park MH. Allosensitization in heart transplantation: implications and management strategies. Curr Opin Cardiol. 2003 Mar; 18(2):153-8.
    View in: PubMed
  178. Richardson WS, Surowiec WJ, Carter KM, Howell TP, Mehra MR, Bowen JC. Gallstone disease in heart transplant recipients. Ann Surg. 2003 Feb; 237(2):273-6.
    View in: PubMed
  179. Mehra MR, Ventura HO, Uber PA, Scott RL, Park MH. Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity-quality paradox. J Heart Lung Transplant. 2003 Feb; 22(2):118-23.
    View in: PubMed
  180. Uber PA, Mehra MR, Park MH, Scott RL. Clopidogrel and rhabdomyolysis after heart transplantation. J Heart Lung Transplant. 2003 Jan; 22(1):107-8.
    View in: PubMed
  181. Morshedi-Meibodi A, Uber PA, Mehra MR. Difficult cases in heart failure: chemotherapy-related cardiomyopathy--all that glitters is not gold. Congest Heart Fail. 2003 Jan-Feb; 9(1):47-9.
    View in: PubMed
  182. Mehra MR, Uber PA, Scott RL, Park MH. Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. Transplantation. 2002 Dec 15; 74(11):1568-73.
    View in: PubMed
  183. Park MH, Scott RL, Uber PA, Harris BC, Chambers R, Mehra MR. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function. Am J Cardiol. 2002 Dec 15; 90(12):1326-9.
    View in: PubMed
  184. Toda K, Mackenzie K, Mehra MR, DiCorte CJ, Davis JE, McFadden PM, Ochsner JL, White C, Van Meter CH. Revascularization in severe ventricular dysfunction (15% < OR = LVEF < OR = 30%): a comparison of bypass grafting and percutaneous intervention. Ann Thorac Surg. 2002 Dec; 74(6):2082-7; discussion 2087.
    View in: PubMed
  185. Messerli FH, Mehra MR. Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [LIFE] Study). Am J Cardiol. 2002 Nov 15; 90(10):1133-4.
    View in: PubMed
  186. Mehra MR, Uber PA, Vivekananthan K, Solis S, Scott RL, Park MH, Milani RV, Lavie CJ. Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival. J Am Coll Cardiol. 2002 Nov 6; 40(9):1609-14.
    View in: PubMed
  187. Mehra MR, Uber PA, Potluri S. Renin angiotensin aldosterone and adrenergic modulation in chronic heart failure: contemporary concepts. Am J Med Sci. 2002 Nov; 324(5):267-75.
    View in: PubMed
  188. Park MH, Scott RL, Uber PA, Mehra MR. Treatment of pulmonary hypertension: a promising new age. Catheter Cardiovasc Interv. 2002 Nov; 57(3):395-403.
    View in: PubMed
  189. Vivekananthan K, Kalapura T, Mehra M, Lavie C, Milani R, Scott R, Park M. Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection. Am J Cardiol. 2002 Sep 1; 90(5):517-20.
    View in: PubMed
  190. Mehra MR, Uber PA, Scott RL, Park MH, Milani RV. Effect of immunosuppressive regimen on novel markers of atherothrombosis in heart transplantation: homocysteine, c-reactive protein, and mean platelet volume. Transplant Proc. 2002 Aug; 34(5):1866-8.
    View in: PubMed
  191. Uber PA, Mehra MR, Harris B, Scott RL, Park MH. Steroid weaning in heart transplantation is associated with decreased B-type natriuretic peptide: surrogate evidence for cardiac adaptation. Transplant Proc. 2002 Aug; 34(5):1843-4.
    View in: PubMed
  192. Mehra MR, Uber PA. Calcineurin-inhibitor withdrawal in heart transplantation recipients (the case against). Transplant Proc. 2002 Aug; 34(5):1825-7.
    View in: PubMed
  193. Sangha SS, Uber PA, Park MH, Scott RL, Mehra MR. Difficult cases in heart failure: the challenge of neurocognitive dysfunction in severe heart failure. Congest Heart Fail. 2002 Jul-Aug; 8(4):232-4.
    View in: PubMed
  194. Mehra MR, Uber PA. Emergence of Laplace therapeutics: declaring an end to end-stage heart failure. Congest Heart Fail. 2002 Jul-Aug; 8(4):228-31, 234.
    View in: PubMed
  195. Lavie CJ, Milani R, Mehra MR, Ventura HO, Messerli FH. Obesity, weight reduction and survival in heart failure. J Am Coll Cardiol. 2002 May 1; 39(9):1563; author reply 1563-4.
    View in: PubMed
  196. Mehra MR, Uber PA, Potluri S, Ventura HO. Is heart failure with preserved systolic function an overlooked enigma? Curr Cardiol Rep. 2002 May; 4(3):187-93.
    View in: PubMed
  197. Park MH, Scott RL, Uber PA, Mehra MR. Bedside b-type natriuretic peptide and acute non-cellular cardiac allograft rejection. J Heart Lung Transplant. 2002 May; 21(5):613-4.
    View in: PubMed
  198. Berman AE, Roca T, Uber P, Mehra M. Neonatal congenital heart disease and "complex" heart failure. Congest Heart Fail. 2002 May-Jun; 8(3):188-90.
    View in: PubMed
  199. Mehra MR. A specialist-nurse intervention reduced readmissions in patients hospitalized with chronic heart failure. ACP J Club. 2002 May-Jun; 136(3):87.
    View in: PubMed
  200. Vivekananthan K, Mehra MR, Uber PA, DeGruiter H, Lavie CJ, Milani RV. Comparison of the efficacy and safety of pravastatin and simvastatin in heart transplantation. J Assoc Physicians India. 2002 May; 50(5):682-4.
    View in: PubMed
  201. Sangha S, Uber PA, Mehra MR. Difficult cases in heart failure: amiodarone lung injury: another heart failure mimic? Congest Heart Fail. 2002 Mar-Apr; 8(2):93-6.
    View in: PubMed
  202. Mehra MR, Uber PA, Uber WE, Park MH, Scott RL. Anything but a biopsy: noninvasive monitoring for cardiac allograft rejection. Curr Opin Cardiol. 2002 Mar; 17(2):131-6.
    View in: PubMed
  203. Mehra MR, Uber PA. The dilemma of late-stage heart failure. Rationale for chronic parenteral inotropic support. Cardiol Clin. 2001 Nov; 19(4):627-36.
    View in: PubMed
  204. Khokhar A, Mehra M. Life style and morbidity profile of geriatric population in an urbans community of Delhi. Indian J Med Sci. 2001 Nov; 55(11):609-15.
    View in: PubMed
  205. Mehra M, Bahar RJ, Ament ME, Waldhausen J, Gershman G, Georgeson K, Fox V, Fishman S, Werlin S, Sato T, Hill I, Tolia V, Atkinson J. Laparoscopic and thoracoscopic esophagomyotomy for children with achalasia. J Pediatr Gastroenterol Nutr. 2001 Oct; 33(4):466-71.
    View in: PubMed
  206. Beckman EN, Mehra MR, Park MH, Scott RL. Utility of heart biopsy in transplant patients. Ochsner J. 2001 Oct; 3(4):219-22.
    View in: PubMed
  207. Ventura HO, Mehra MR, Young JB. Treatment of heart failure according to William Stokes: the enchanted mercury. J Card Fail. 2001 Sep; 7(3):277-82.
    View in: PubMed
  208. Ventura HO, Mehra MR, Messerli FH. Desperate diseases, desperate measures: tackling malignant hypertension in the 1950s. Am Heart J. 2001 Aug; 142(2):197-203.
    View in: PubMed
  209. Ali A, Mehra MR, Malik FS, Uber PA, Ventura HO. Insights into ventricular repolarization abnormalities in cardiac allograft vasculopathy. Am J Cardiol. 2001 Feb 1; 87(3):367-8, A10.
    View in: PubMed
  210. Uber PA, Mehra MR, Scott RL, Prasad AK, Park MH. Ethnic disparities in the pharmacologic characteristics of tacrolimus in heart transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1581-2.
    View in: PubMed
  211. Mehra MR, Uber PA, Scott RL, Prasad AK, Park MH. Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1613-4.
    View in: PubMed
  212. Mehra MR, Uber PA, Park MH, Prasad AK, Scott RL. A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients. Transplant Proc. 2001 Feb-Mar; 33(1-2):1606-7.
    View in: PubMed
  213. Eisen HJ, Hobbs RE, Davis SF, Carrier M, Mancini DM, Smith A, Valantine H, Ventura H, Mehra M, Vachiery JL, Rayburn BK, Canver CC, Laufer G, Costanzo MR, Copeland J, Dureau G, Frazier OH, Dorent R, Hauptman PJ, Kells C, Masters R, Michaud JL, Paradis I, Renlund DG, Vanhaecke J, Mellein B, Mueller EA. Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation. Transplantation. 2001 Jan 15; 71(1):70-8.
    View in: PubMed
  214. Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV. The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol. 2000 Dec; 36(7):2126-31.
    View in: PubMed
  215. Lal P, Singh MM, Mehra M. Difficulties of the staff posted for intensive pulse polio immunization in Delhi. Indian J Med Sci. 2000 Nov; 54(11):481-4.
    View in: PubMed
  216. Mehra MR, Uber PA, Prasad AK, Park MH, Scott RL, McFadden PM, Van Meter CH. Long-term outcome of cardiac allograft vasculopathy treated by transmyocardial laser revascularization: early rewards, late losses. J Heart Lung Transplant. 2000 Aug; 19(8):801-4.
    View in: PubMed
  217. Ventura HO, Mehra MR, Young JB. Robert James Graves and the cardiovascular responses to postural changes in heart failure. Am J Cardiol. 2000 Jun 15; 85(12):1503-6; A8.
    View in: PubMed
  218. Mehra MR. Crossing the vasculopathy bridge from morphology to therapy: a single center experience. J Heart Lung Transplant. 2000 Jun; 19(6):522-8.
    View in: PubMed
  219. Lucini D, Milani RV, Ventura HO, Mehra MR, Messerli F, Pagani M. Study of arterial and autonomic effects of cyclosporine in humans. Hypertension. 2000 Jun; 35(6):1258-63.
    View in: PubMed
  220. Mehra MR. The 500 heart transplant. Ochsner J. 2000 Apr; 2(2):120-1.
    View in: PubMed
  221. Prasad A, Mehra M, Park M, Scott R, Uber PA, McFadden PM. Cardiac allograft valvulopathy: a case of donor-anorexigen-induced valvular disease. Ann Thorac Surg. 1999 Nov; 68(5):1840-1.
    View in: PubMed
  222. Ali A, Mehra MR, Malik FS, Lavie CJ, Bass D, Milani RV. Effects of aerobic exercise training on indices of ventricular repolarization in patients with chronic heart failure. Chest. 1999 Jul; 116(1):83-7.
    View in: PubMed
  223. Mehra MR. The emergence of a dynamic intervention paradigm in heart failure. Ochsner J. 1999 Apr; 1(2):63-6.
    View in: PubMed
  224. Malik FS, Mehra MR, Uber PA, Park MH, Scott RL, Van Meter CH. Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock. J Card Fail. 1999 Mar; 5(1):31-7.
    View in: PubMed
  225. Ali A, Mehra MR, Lavie CJ, Malik FS, Murgo JP, Lohmann TP, Li S, Lin HC, Milani RV. Modulatory impact of cardiac rehabilitation on hyperhomocysteinemia in patients with coronary artery disease and "normal" lipid levels. Am J Cardiol. 1998 Dec 15; 82(12):1543-5, A8.
    View in: PubMed
  226. Jain SP, Ramee SR, White CJ, Mehra MR, Ventura HO, Zhang S, Jenkins JS, Collins TJ. Coronary stenting in cardiac allograft vasculopathy. J Am Coll Cardiol. 1998 Nov 15; 32(6):1636-40.
    View in: PubMed
  227. Harjai KJ, Boulos LM, Smart FW, Turgut T, Krousel-Wood MA, Stapleton DD, Mehra MR, Murgo JP, Ventura HO. Effects of caregiver specialty on cost and clinical outcomes following hospitalization for heart failure. Am J Cardiol. 1998 Jul 1; 82(1):82-5.
    View in: PubMed
  228. Ventura HO, Mehra MR. Colles-Stokes contributions to the concept of heart failure. Am J Cardiol. 1998 Jun 15; 81(12):1470-3.
    View in: PubMed
  229. Mehra MR. From crisis intervention to preventive intervention. A new approach to the management of heart failure. Tex Heart Inst J. 1998; 25(4):251-4.
    View in: PubMed
  230. Harjai KJ, Mehra MR, Ventura HO, Lapeyre YM, Murgo JP, Stapleton DD, Smart FW. Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes. Chest. 1997 Nov 5; 112(5):1298-303.
    View in: PubMed
  231. Richards DR, Mehra MR, Ventura HO, Lavie CJ, Smart FW, Stapleton DD, Milani RV. Usefulness of peak oxygen consumption in predicting outcome of heart failure in women versus men. Am J Cardiol. 1997 Nov 1; 80(9):1236-8.
    View in: PubMed
  232. Ventura HO, Mehra MR, Stapleton DD, Smart FW. Cyclosporine-induced hypertension in cardiac transplantation. Med Clin North Am. 1997 Nov; 81(6):1347-57.
    View in: PubMed
  233. Stapleton DD, Mehra MR, Dumas D, Smart FW, Milani RV, Lavie CJ, Ventura HO. Lipid-lowering therapy and long-term survival in heart transplantation. Am J Cardiol. 1997 Sep 15; 80(6):802-5.
    View in: PubMed
  234. Malik FS, Lavie CJ, Mehra MR, Milani RV, Re RN. Renin-angiotensin system: genes to bedside. Am Heart J. 1997 Sep; 134(3):514-26.
    View in: PubMed
  235. Manord JD, Garrard CL, Mehra MR, Sternbergh WC, Ballinger B, Ventura HO, Stapleton DD, Smart FW, Bowen JC, Money SR. Implications for the vascular surgeon with prolonged (3 to 89 days) intraaortic balloon pump counterpulsation. J Vasc Surg. 1997 Sep; 26(3):511-5; discussion 515-6.
    View in: PubMed
  236. Malik FS, Mehra MR, Ventura HO, Smart FW, Stapleton DD, Ochsner JL. Management of cardiac allograft vasculopathy by transmyocardial laser revascularization. Am J Cardiol. 1997 Jul 15; 80(2):224-5.
    View in: PubMed
  237. Ventura HO, Malik FS, Mehra MR, Stapleton DD, Smart FW. Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine. Curr Opin Cardiol. 1997 Jul; 12(4):375-81.
    View in: PubMed
  238. Mehra MR, Ventura HO, Kapoor C, Stapleton DD, Zimmerman D, Smart FW. Safety and clinical utility of long-term intravenous milrinone in advanced heart failure. Am J Cardiol. 1997 Jul 1; 80(1):61-4.
    View in: PubMed
  239. Mehra MR, Cassidy CA, deGruiter HG, Ventura HO. The unique management of refractory advanced systolic heart failure. Heart Lung. 1997 Jul-Aug; 26(4):280-8.
    View in: PubMed
  240. Mehra MR, Ventura HO, Chambers RB, Ramireddy K, Smart FW, Stapleton DD. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal. J Heart Lung Transplant. 1997 Jul; 16(7):743-51.
    View in: PubMed
  241. Bhatia DS, Bowen JC, Money SR, Van Meter CH, McFadden PM, Kot JB, Pridjian AK, Ventura HO, Mehra MR, Smart FW, Ochsner JL. The incidence, morbidity, and mortality of surgical procedures after orthotopic heart transplantation. Ann Surg. 1997 Jun; 225(6):686-93; discussion 693-4.
    View in: PubMed
  242. Mehra MR, Ventura HO, Stapleton DD, Karsan AK, Smart FW, Ramee SR, Collins TJ. Allograft aortopathy: an in vivo study of donor aorta involvement in cardiac allograft vasculopathy. Am Heart J. 1997 Jun; 133(6):698-702.
    View in: PubMed
  243. Kumar A, Mehra M, Badhan SK, Gulati N. Heterosexual behaviour and condom usage in an urban population of Delhi, India. AIDS Care. 1997 Jun; 9(3):311-8.
    View in: PubMed
  244. Lucini D, Milani RV, Ventura HO, Mehra MR, Messerli FH, Murgo JP, Regenstein F, Copley B, Malliani A, Pagani M. Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control. J Heart Lung Transplant. 1997 Jun; 16(6):615-20.
    View in: PubMed
  245. Mehra MR, Ventura HO, Jain SP, Ramireddy K, Ali A, Stapleton DD, Smart FW, Ramee SR, Collins TJ, White CJ. Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopy. J Am Coll Cardiol. 1997 May; 29(6):1339-44.
    View in: PubMed
  246. Milani RV, Mehra MR, Reddy TK, Lavie CJ, Ventura HO. Ventilation/carbon dioxide production ratio in early exercise predicts poor functional capacity in congestive heart failure. Heart. 1996 Nov; 76(5):393-6.
    View in: PubMed
  247. Milani RV, Mehra MR, Endres S, Eigler A, Cooper ES, Lavie CJ, Ventura HO. The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia. Chest. 1996 Oct; 110(4):992-5.
    View in: PubMed
  248. Mehra MR, Lavie CJ, Milani RV. Predicting prognosis in advanced heart failure. Use of exercise indices. Chest. 1996 Aug; 110(2):310-2.
    View in: PubMed
  249. Mehra MR, Stapleton DD, Cook JL, Zhang T, Ventura HO, Huang C, Maldonado B, Smart FW, Re RN, Murgo JP, Barbee RW. Adenovirus-mediated in vivo gene transfer in a rabbit model of allograft vasculopathy. J Heart Lung Transplant. 1996 Jan; 15(1 Pt 1):51-7.
    View in: PubMed
  250. Gulati N, Kumar A, Lal P, Mehra M, Sahgal K. Preventing gastro-enteritis deaths: recommendations based on a 3 years study. J Commun Dis. 1995 Dec; 27(4):256-61.
    View in: PubMed
  251. Mehra MR, Ventura HO, Chambers R, Collins TJ, Ramee SR, Kates MA, Smart FW, Stapleton DD. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol. 1995 Nov 15; 26(6):1537-44.
    View in: PubMed
  252. Mehra MR, Ventura HO, Stapleton DD, Smart FW. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift. J Heart Lung Transplant. 1995 Nov-Dec; 14(6 Pt 2):S207-11.
    View in: PubMed
  253. Mehra MR, Ventura HO, Smart FW, Stapleton DD. Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside. J Heart Lung Transplant. 1995 Nov-Dec; 14(6 Pt 2):S246-9.
    View in: PubMed
  254. Mehra MR, Lavie CJ, Ventura HO, Milani RV. Prevention of atherosclerosis. The potential role of antioxidants. Postgrad Med. 1995 Jul; 98(1):175-6, 179-84.
    View in: PubMed
  255. Mehra MR, Ventura HO, Stapleton DD, Smart FW, Collins TC, Ramee SR. Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy. J Heart Lung Transplant. 1995 Jul-Aug; 14(4):632-9.
    View in: PubMed
  256. Mehra MR, Ventura HO, Escobar A, Cassidy CA, Smart FW, Stapleton DD. Does donor and recipient sex influence the development of cardiac allograft vasculopathy? Transplant Proc. 1995 Jun; 27(3):1926-9.
    View in: PubMed
  257. Ali A, Mehra MR, Stapleton DD, Kemmerly SA, Ramireddy K, Smart FW, Augustine S, Ventura HO. Vibrio vulnificus sepsis in solid organ transplantation: a medical nemesis. J Heart Lung Transplant. 1995 May-Jun; 14(3):598-600.
    View in: PubMed
  258. Mehra MR, Ventura HO, Smart FW, Collins TJ, Ramee SR, Stapleton DD. An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy. Am J Cardiol. 1995 Apr 15; 75(12):853-4.
    View in: PubMed
  259. Ventura HO, Mehra MR, Smart FW, Stapleton DD. Cardiac allograft vasculopathy: current concepts. Am Heart J. 1995 Apr; 129(4):791-9.
    View in: PubMed
  260. Mehra MR, Ventura HO, Smart FW, Stapleton DD, Collins TJ, Ramee SR, Murgo JP, White CJ. New developments in the diagnosis and management of cardiac allograft vasculopathy. Tex Heart Inst J. 1995; 22(2):138-44.
    View in: PubMed
  261. Escobar A, Ventura HO, Stapleton DD, Mehra MR, Ramee SR, Collins TJ, Jain SP, Smart FW, White CJ. Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors. Am J Cardiol. 1994 Nov 15; 74(10):1042-6.
    View in: PubMed
  262. Mehra MR, Stapleton DD, Ventura HO, Escobar A, Cassidy CA, Smart FW, Collins TJ, Ramee SR, White CJ. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study. Circulation. 1994 Nov; 90(5 Pt 2):II78-82.
    View in: PubMed
  263. Jacotot B, Banga JD, Pfister P, Mehra M. Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study Group. Br J Clin Pharmacol. 1994 Sep; 38(3):257-63.
    View in: PubMed
  264. Peters TK, Muratti EN, Mehra M. Fluvastatin in primary hypercholesterolemia: efficacy and safety in patients at high risk. An analysis of a clinical trial database. Am J Med. 1994 Jun 6; 96(6A):79S-83S.
    View in: PubMed
  265. Banga JD, Jacotot B, Pfister P, Mehra M. Long-term treatment of hypercholesterolemia with fluvastatin: a 52-week multicenter safety and efficacy study. French-Dutch Fluvastatin Study Group. Am J Med. 1994 Jun 6; 96(6A):87S-93S.
    View in: PubMed
  266. Peters TK, Muratti EN, Mehra M. Efficacy and safety of fluvastatin in women with primary hypercholesterolaemia. Drugs. 1994; 47 Suppl 2:64-72.
    View in: PubMed
  267. Peters TK, Mehra M, Muratti EN. Efficacy and safety of fluvastatin in hypertensive patients. An analysis of a clinical trial database. Am J Hypertens. 1993 Nov; 6(11 Pt 2):340S-345S.
    View in: PubMed
  268. Peters TK, Jewitt-Harris J, Mehra M, Muratti EN. Safety and tolerability of fluvastatin with concomitant use of antihypertensive agents. An analysis of a clinical trial database. Am J Hypertens. 1993 Nov; 6(11 Pt 2):346S-352S.
    View in: PubMed
  269. Mehra MR, Sharif K, Bode FR. Radiocontrast-induced nephropathy. Prevention is better than cure. Postgrad Med. 1992 Dec; 92(8):215-8, 222-3.
    View in: PubMed
  270. Gaglani RD, Turk AA, Mehra MR, Lach RD. Ventricular standstill complicating left heart catheterization in the presence of uncomplicated right bundle branch block. Cathet Cardiovasc Diagn. 1992 Nov; 27(3):212-4.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Mehra's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (729) concept(s)
_
Co-Authors
See all (15) people
_
Similar People
See all (60) people
_
Same Department
Search Department